Archive - March 2018
Association health plan rule poses financial threat for providers
News of Note—Bavarian Nordic, universal flu vaccine and more
Drug shown to reverse brain deficits caused by alcohol
Novartis teams up with American company to launch remote trials
Theratechnologies’ last-ditch HIV drug approved by FDA
Cambridge BioMarketing tells rare-disease stories with new podcast series
Bristol-Myers Squibb’s Opdivo® (nivolumab) now the first and only FDA-approved PD-1 inhibitor to offer every four-week dosing
UnitedHealth tightens reins on emergency department reimbursement